HERPLEX
LOE ApproachingNDAOPHTHALMICSOLUTION/DROPSPriority Review
Approved
Jun 1963
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 2d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
HERPLEX is an ophthalmic solution approved in 1963 for the treatment of herpes simplex keratitis and other corneal viral infections. As a small-molecule antiviral drop, it works by inhibiting viral replication in ocular tissues. The product represents a legacy antiviral therapy in ophthalmology with a well-established but aging safety profile.
LOE Approaching
Product is in LOE phase with low competitive pressure (30%), suggesting small, maintenance-focused brand team focused on retention and physician loyalty rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on HERPLEX offers stability in a legacy franchise but limited career acceleration; the product is in LOE phase with minimal linked job postings and no clinical expansion pipeline. This role is best suited for professionals seeking ophthalmology expertise, physician relationship building, or market defense experience rather than launch or growth opportunities.
Brand Manager
Worked on HERPLEX at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.